A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.

The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with ...

AI-supported breast cancer screening increased early-stage cancer detection while reducing radiologists’ workload without increasing false positives, but more research is needed before clinical ...

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the first enrollment in Europe in the AAA-SHAPE Pivotal Trial, the Company’s prospective, ...

As COVID-19 continues to evolve into new variants, it is clear that the virus is here to stay. With vaccines no longer at the center of public discourse and their safety is in question against ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

You can add it to your coffee, cook it fresh or pop as a pill – but does this popular mushroom actually supercharge your ...

When transitioning from prison to the community, formerly incarcerated individuals face numerous challenges, including lack ...

SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.

Researchers at Penn Medicine conducted a pilot randomized controlled trial to test the hypothesis that an e-triage ...

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds they average 5 hours ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.